BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatitis B Surface antigen
1
Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
10/24/2025 7:36:34 AM | Browse: 216 | Download: 341
2
Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B
10/24/2025 7:36:26 AM | Browse: 178 | Download: 280
3
Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure
1/6/2025 8:47:57 AM | Browse: 172 | Download: 663
4
False occult hepatitis B infection with negative hepatitis B surface antigen while positive hepatitis B envelope antigen: A case report
10/21/2024 7:03:24 AM | Browse: 165 | Download: 987
5
Immunoprophylaxis failure and vaccine response in infants born to mothers with chronic hepatitis B infection in Djibouti
7/26/2024 10:33:30 AM | Browse: 216 | Download: 1288
6
Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer
3/27/2023 2:19:30 PM | Browse: 427 | Download: 1426
7
Chronic hepatitis B: New potential therapeutic drugs target
1/15/2022 7:06:22 AM | Browse: 622 | Download: 1331
8
Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families
9/29/2021 11:12:00 AM | Browse: 758 | Download: 2077
9
Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis
9/22/2021 8:09:41 AM | Browse: 812 | Download: 1835
10
Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment
7/21/2021 8:24:09 AM | Browse: 628 | Download: 2230
11
Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach
6/18/2021 5:06:16 AM | Browse: 595 | Download: 1688
12
Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleoside analogues in hepatitis B e antigen-negative patients
11/24/2020 12:41:22 PM | Browse: 824 | Download: 2331
13
Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations
9/17/2020 1:56:14 AM | Browse: 855 | Download: 2514
14
Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA
9/27/2018 9:38:46 AM | Browse: 1239 | Download: 1901
15
Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
2/6/2018 3:22:41 AM | Browse: 1329 | Download: 2515
16
miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma
7/7/2017 11:41:16 AM | Browse: 1441 | Download: 1873
17
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors
3/28/2017 10:34:00 AM | Browse: 1373 | Download: 1738
18
Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015
12/6/2016 8:33:00 AM | Browse: 1292 | Download: 2693
19
Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study
11/26/2016 6:56:00 PM | Browse: 1482 | Download: 2441
20
Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial
5/12/2016 10:38:00 AM | Browse: 1463 | Download: 2635
21
Genetic variation of occult hepatitis B virus infection
3/28/2016 3:05:00 PM | Browse: 1278 | Download: 2103
22
Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma
3/23/2016 4:26:00 PM | Browse: 1525 | Download: 2433
23
Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited
3/11/2016 9:54:00 AM | Browse: 1585 | Download: 2413
24
Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patients
7/30/2015 11:19:00 AM | Browse: 1055 | Download: 2399
25
Seroepidemiology of hepatitis B virus infection and impact of vaccination
7/8/2015 12:00:00 PM | Browse: 1425 | Download: 2963
26
Induced immunity against hepatitis B virus
6/29/2015 5:40:00 PM | Browse: 1107 | Download: 2295
27
Applications of human hepatitis B virus preS domain in bio- and nanotechnology
6/29/2015 4:40:00 PM | Browse: 1527 | Download: 2387
28
Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
5/1/2015 7:01:00 PM | Browse: 1537 | Download: 2309
29
Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity
2/11/2015 5:56:00 PM | Browse: 1419 | Download: 1901
30
Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion
1/18/2015 4:09:00 PM | Browse: 1455 | Download: 1773
31
Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt
9/12/2014 8:40:00 PM | Browse: 1262 | Download: 1534
32
HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions
8/29/2014 11:31:00 AM | Browse: 1276 | Download: 1605
33
Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin’s lymphoma
8/28/2014 3:52:00 PM | Browse: 1226 | Download: 1711
34
Association between metabolic factors and chronic hepatitis B virus infection
8/26/2014 2:46:00 PM | Browse: 1399 | Download: 1688
35
Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues
8/26/2014 1:51:00 PM | Browse: 1176 | Download: 1684
36
Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients
8/26/2014 11:43:00 AM | Browse: 1144 | Download: 1451
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.